Clinical Masaoka Stage II to IVA
1 clinical trials · Condition
◉ Watch Clinical Masaoka Stage II to IVA
| Record | Firm | Date |
|---|---|---|
| Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma (NCT01025089) | Memorial Sloan Kettering Cancer Center | 2009-12-01 |
Track Clinical Masaoka Stage II to IVA automatically
Every clearance here is in the API, with alerts when new ones post.